✦ LIBER ✦

P-567 Topotecan/carboplatin 5 days versus topotecan/carboplatin 3 days in patients with metastasic small cell lung cancer

✍ Scribed by Seifart, U.L.F.; Fink, U.; Hans, K.; Mueller, C.; Koschel, G.; Schroeder, H.; Lorenz, R.; Staab, H.J.; Neubauer, A.; Wolf, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topotecan–carboplatin–etoposide combinat

✍ Zarogoulidis, K.; Mylonaki, E.; Kakavelas, P.; Zarogoulidis, P.; Tsiouda, Th.; R 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 258 KB

P-563 Phase I study of sequential topote

✍ Miller, Antonius A.; Tucker, Robert; Lesser, Glenn; Case, Doug 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A phase I study of 3-day topotecan and c

✍ Keiichi Fujiwara; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigaw 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 198 KB

Phase I and pharmacologic study of seque

✍ Miller, Antonius A.; Al Omari, Amal; Murry, Daryl J.; Case, Doug 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Randomized phase II study comparing topo

✍ Seifart, U.; Jensen, K.; Ukena, J.; Mueller, C.; Schröder, M.; Fuhr, H.G.; Keppl 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Gemcitabine/Carboplatin in Patients with

✍ Coleman K. Obasaju; Zhishen Ye; Leslie P. Bloss; Matthew J. Monberg; Rafael E. C 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 139 KB